4/A//SEC Filing
Grooms Jamie Mark 4/A
Accession 0001104659-18-010448
CIK 0000805928other
Filed
Feb 15, 7:00 PM ET
Accepted
Feb 16, 8:14 PM ET
Size
14.5 KB
Accession
0001104659-18-010448
Insider Transaction Report
Form 4/AAmended
AxoGen, Inc.AXGN
Grooms Jamie Mark
Director
Transactions
- Sale
Common Stock
2018-02-13$26.20/sh−7,100$186,020→ 202,595 total(indirect: See Footnote) - Sale
Common Stock
2018-02-13$26.22/sh−3,200$83,904→ 9,073 total(indirect: See Footnote) - Sale
Common Stock
2018-02-14$26.71/sh−9,073$242,340→ 0 total(indirect: See Footnote) - Sale
Common Stock
2018-02-14$26.72/sh−32,936$880,050→ 169,659 total(indirect: See Footnote) - Sale
Common Stock
2018-02-15$27.11/sh−43,403$1,176,655→ 126,256 total(indirect: See Footnote)
Footnotes (8)
- [F1]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.00 to $26.55. The reporting person undertakes to provide to AxoGen, Inc., any security holder of AxoGen, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- [F2]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.00 to $26.60. The reporting person undertakes to provide to AxoGen, Inc., any security holder of AxoGen, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- [F3]These shares of common stock are held indirectly by the reporting person through the Jamie Grooms Trust, of which Mr. Grooms is a trustee.
- [F4]These shares of common stock are held indirectly by the reporting person through the Jamie Grooms Children's Trust, of which Mr. Grooms is a trustee.
- [F5]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.10 to $27.05. The reporting person undertakes to provide to AxoGen, Inc., any security holder of AxoGen, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- [F6]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.20 to $26.95. The reporting person undertakes to provide to AxoGen, Inc., any security holder of AxoGen, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- [F7]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.50 to $27.375. The reporting person undertakes to provide to AxoGen, Inc., any security holder of AxoGen, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- [F8]The transactions reported on the original Form 4 filed on February 15, 2018 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 13, 2017.
Documents
Issuer
AxoGen, Inc.
CIK 0000805928
Entity typeother
Related Parties
1- filerCIK 0001530935
Filing Metadata
- Form type
- 4/A
- Filed
- Feb 15, 7:00 PM ET
- Accepted
- Feb 16, 8:14 PM ET
- Size
- 14.5 KB